Extraordinary General Meeting to address the proposal by a group of shareholders that Diamyd Medical enter into immediate liquidation

On February 8, 2013, a group of shareholders submitted a request in writing to the Board of Directors of Diamyd Medical that the Board convene an extraordinary General Meeting to address their proposal that Diamyd Medical enter into immediate liquidation. The shareholders claimed to represent 8,883,351 Series B shares in Diamyd, corresponding to about 21 percent of the votes and 30 percent of the total number of shares. In addition to the proposed liquidation, the group of shareholders proposes that the General Meeting elect a new Board of Directors, that the company change its name to